Transglutaminase type 2 plays a key role in the pathogenesis of Mycobacterium tuberculosis infection

ConclusionThese results suggest that inhibition of TG2 activity is a potential novel approach for the treatment of TB.

Source: Journal of Internal Medicine - December 4, 2017 Category: Internal Medicine Authors: I. Palucci, I. Matic, L. Falasca, M. Minerva, G. Maulucci, M. De Spirito, E. Petruccioli, D. Goletti, F. Rossin, M. Piacentini, G. Delogu Tags: Original Article Source Type: research